These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

479 related items for PubMed ID: 19014846

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Adherence to a fixed-dose combination of rosiglitazone maleate/metformin hydrochloride in subjects with type 2 diabetes mellitus: a retrospective database analysis.
    Vanderpoel DR, Hussein MA, Watson-Heidari T, Perry A.
    Clin Ther; 2004 Dec; 26(12):2066-75. PubMed ID: 15823770
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Health care costs and medication adherence associated with initiation of insulin pen therapy in Medicaid-enrolled patients with type 2 diabetes: a retrospective database analysis.
    Pawaskar MD, Camacho FT, Anderson RT, Cobden D, Joshi AV, Balkrishnan R.
    Clin Ther; 2007 Jun; 29(6 Pt 1):1294-305. PubMed ID: 18036391
    [Abstract] [Full Text] [Related]

  • 6. Adherence to oral antidiabetic medications in the pediatric population with type 2 diabetes: a retrospective database analysis.
    Adeyemi AO, Rascati KL, Lawson KA, Strassels SA.
    Clin Ther; 2012 Mar; 34(3):712-9. PubMed ID: 22381712
    [Abstract] [Full Text] [Related]

  • 7. Adherence with pharmacotherapy for type 2 diabetes: a retrospective cohort study of adults with employer-sponsored health insurance.
    Hertz RP, Unger AN, Lustik MB.
    Clin Ther; 2005 Jul; 27(7):1064-73. PubMed ID: 16154485
    [Abstract] [Full Text] [Related]

  • 8. An empirical basis for standardizing adherence measures derived from administrative claims data among diabetic patients.
    Karve S, Cleves MA, Helm M, Hudson TJ, West DS, Martin BC.
    Med Care; 2008 Nov; 46(11):1125-33. PubMed ID: 18953222
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Oral antidiabetic therapy in a large Italian sample: drug supply and compliance for different therapeutic regimens.
    Vittorino Gaddi A, Benedetto D, Capello F, Di Pietro C, Cinconze E, Rossi E, De Sando V, Cevenini M, D'Alò G.
    Public Health; 2014 Jan; 128(1):70-6. PubMed ID: 23969148
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Baseline characteristic differences between patients prescribed sitagliptin vs. other oral antihyperglycemic agents: analysis of a US electronic medical record database.
    Zhang Q, Rajagopalan S, Mavros P, Engel SS, Davies MJ, Yin D, Radican L.
    Curr Med Res Opin; 2010 Jul; 26(7):1697-703. PubMed ID: 20465367
    [Abstract] [Full Text] [Related]

  • 19. Variation in antidiabetic medication intensity among Medicare beneficiaries with diabetes mellitus.
    Stuart B, Shaffer TJ, Simoni-Wastila LJ, Zuckerman IH, Quinn CC.
    Am J Geriatr Pharmacother; 2007 Sep; 5(3):195-208. PubMed ID: 17996659
    [Abstract] [Full Text] [Related]

  • 20. Health outcomes and economic impact of therapy conversion to a biphasic insulin analog pen among privately insured patients with type 2 diabetes mellitus.
    Cobden D, Lee WC, Balu S, Joshi AV, Pashos CL.
    Pharmacotherapy; 2007 Jul; 27(7):948-62. PubMed ID: 17594200
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.